Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Omar Almazroo"'
Autor:
Abdullah Alsultan, Wael A. Alghamdi, Jahad Alghamdi, Abeer F. Alharbi, Abdullah Aljutayli, Ahmed Albassam, Omar Almazroo, Saeed Alqahtani
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 10, Pp 1217-1227 (2020)
Drug development, from preclinical to clinical studies, is a lengthy and complex process. There is an increased interest in the Kingdom of Saudi Arabia (KSA) to promote innovation, research and local content including clinical trials (Phase I-IV). Cu
Externí odkaz:
https://doaj.org/article/f1f28a8e4c3344b688db0ebc2fb274f3
Autor:
Rawan Alenazi, Shatha Asiri, Saja Almazrou, Wejdan R. Alsharif, Badr Aljohani, Ghadah S. Almuaythir, Yazed AlRuthia, Hala H. Alrasheed, Bushra M. Alghamdi, Maryam Alarfaj, Ahmed L. Alaofi, Omar Almazroo
Publikováno v:
Health Policy and Technology. 10:120-125
Background The recent incidents of generic drug recalls have shaken the public confidence in the quality of generic drugs in Saudi Arabia. Therefore, many clinicians and health policymakers are calling for the establishment of a national reference or
Autor:
Abeer F. Alharbi, Abdullah Aljutayli, Saeed Alqahtani, Ahmed A. Albassam, Wael A. Alghamdi, Omar Almazroo, Jahad Alghamdi, Abdullah Alsultan
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 28, Iss 10, Pp 1217-1227 (2020)
Saudi Pharmaceutical Journal, Vol 28, Iss 10, Pp 1217-1227 (2020)
Drug development, from preclinical to clinical studies, is a lengthy and complex process. There is an increased interest in the Kingdom of Saudi Arabia (KSA) to promote innovation, research and local content including clinical trials (Phase I-IV). Cu